Key Insights

Highlights

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05292768Not Yet Recruiting

Are Mast Cells Involved in Autoinflammatory Diseases

Showing all 1 trials

Research Network

Active Sponsors

  • Assistance Publique - Hôpitaux de Paris1
  • Institut Imagine1

Top Investigators

Related Conditions

  • Traps1
  • Autoinflammatory Disease1
  • Cryopyrin Associated Periodic Syndrome1
  • Fmf1
  • Mkd1

Activity Timeline